Chlamydia trachomatis and Mycoplasma genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009-2019.
Hannah S Shilling, Suzanne M Garland, Anna-Maria Costa, Alex Marceglia, Katherine Fethers, Jennifer Danielewski, Gerald Murray, Catriona Bradshaw, Lenka Vodstrcil, Jane S Hocking, John Kaldor, Rebecca Guy, Dorothy A Machalek
Sexually Transmitted Infections | Published : 2021
BACKGROUND: Risk of pelvic inflammatory disease associated with Chlamydia trachomatis and Mycoplasma genitalium is increased after termination of pregnancy (TOP) and may be increased after insertion of intrauterine devices (IUDs). Screening prior to these procedures is recommended only for C. trachomatis. We examined C. trachomatis and M. genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception service over 10 years. METHODS: Retrospective analysis of clinical data collected from 17 573 women aged 15-45 years in 2009-2019 and for 266 M. genitalium positive women tested for macrolide resistance-associated mutations in 2016-2019. RESULTS:..View full abstract